Alzheimer’s disease (AD) is marked by severe neurodegeneration and cognitive decline, presenting significant challenges for its prevention and treatment. Traditional hypotheses have focused on amyloid-beta plaques and Tau pathology, but recent findings point to a significant role for microglial dysfunction and mitochondrial impairment. Given these challenges, there is a pressing need for deeper research into the mechanisms underlying AD.